These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effectiveness and safety of varenicline for smoking cessation]. Christalla P; Dewenter M; El-Armouche A Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478 [TBL] [Abstract][Full Text] [Related]
4. Treatment of nicotine dependence with Chantix (varenicline). Rankin KV; Jones DL Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789 [TBL] [Abstract][Full Text] [Related]
6. Varenicline: a first-line treatment option for smoking cessation. Garrison GD; Dugan SE Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of varenicline for smoking cessation. Hays JT; Ebbert JO; Sood A Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165 [TBL] [Abstract][Full Text] [Related]
8. Varenicline (Chantix) for tobacco dependence. Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281 [No Abstract] [Full Text] [Related]
9. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788 [TBL] [Abstract][Full Text] [Related]
10. Effects of varenicline on smoking cue–triggered neural and craving responses. Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958 [TBL] [Abstract][Full Text] [Related]
11. Drugs for tobacco dependence. Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526 [No Abstract] [Full Text] [Related]
13. Varenicline for tobacco dependence. Cantrell MA; Geraets D N Engl J Med; 2009 Feb; 360(7):730-1. PubMed ID: 19213691 [No Abstract] [Full Text] [Related]
14. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Foulds J Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857 [TBL] [Abstract][Full Text] [Related]
15. Reduced affective symptoms during tobacco dependence treatment with varenicline. Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797 [TBL] [Abstract][Full Text] [Related]
16. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Rose JE; Behm FM Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962 [TBL] [Abstract][Full Text] [Related]
17. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Keating GM; Lyseng-Williamson KA Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995 [TBL] [Abstract][Full Text] [Related]
18. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects! Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119 [No Abstract] [Full Text] [Related]